Invesaro

Stocks Comparison

NewGenIvf vs Sotera Health: revenue, profit, margins and growth compared

NewGenIvf brought in $23.7M of revenue in fiscal 2025, Sotera Health $1.2B in fiscal 2025. Revenue changed by +336.3% at NewGenIvf and +5.7% at Sotera Health on the year before, so NewGenIvf grew faster. NewGenIvf kept 41.7% of its revenue as net profit, Sotera Health 6.7%. Free cash flow was -$11.1M at NewGenIvf and $149.2M at Sotera Health.

Side by side, latest fiscal year

NIVFSHC
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$23.7M$1.2B
Revenue growth+336.3%+5.7%
Net income$9.9M$77.9M
Net margin41.7%6.7%
Free cash flow-$11.1M$149.2M
Free cash flow margin-46.7%12.8%
Earnings per share (diluted)$3.04$0.27
Cash$758.6K$344.6M
Debtn/a$2.1B
Price to earningsn/a67.9
Market value$3.3M$5.2B
Dividend yieldn/an/a
Rank by revenue in sector#425 of 646 · Health care#139 of 646 · Health care

Over the years

Revenue
NIVF FY2021: $4.1MNIVF FY2023: $5.9MNIVF FY2023: $5.1MNIVF FY2024: $5.4MNIVF FY2025: $23.7MSHC FY2019: $778.3MSHC FY2021: $818.2MSHC FY2021: $931.5MSHC FY2022: $1BSHC FY2023: $1BSHC FY2024: $1.1BSHC FY2025: $1.2BFY19FY21FY22FY23FY24FY25
NIVF $23.7MSHC $1.2B
Net income
NIVF FY2021: -$533NIVF FY2023: $458.7KNIVF FY2023: $130.2KNIVF FY2024: -$524.6KNIVF FY2025: $9.9MSHC FY2019: -$20.9MSHC FY2021: -$38.6MSHC FY2021: $116.9MSHC FY2022: -$233.6MSHC FY2023: $51.4MSHC FY2024: $44.4MSHC FY2025: $77.9MFY19FY21FY22FY23FY24FY25
NIVF $9.9MSHC $77.9M
Net margin
NIVF FY2021: -0.0%NIVF FY2023: 7.7%NIVF FY2023: 2.5%NIVF FY2024: -9.7%NIVF FY2025: 41.7%SHC FY2019: -2.7%SHC FY2021: -4.7%SHC FY2021: 12.5%SHC FY2022: -23.3%SHC FY2023: 4.9%SHC FY2024: 4.0%SHC FY2025: 6.7%FY19FY21FY22FY23FY24FY25
NIVF 41.7%SHC 6.7%
Revenue growth
NIVF FY2023: +44.3%NIVF FY2023: -13.6%NIVF FY2024: +5.8%NIVF FY2025: +336.3%SHC FY2021: +5.1%SHC FY2021: +13.9%SHC FY2022: +7.8%SHC FY2023: +4.5%SHC FY2024: +4.9%SHC FY2025: +5.7%FY21FY22FY23FY24FY25
NIVF +336.3%SHC +5.7%
Free cash flow
NIVF FY2021: $1.4MNIVF FY2023: $1.6MNIVF FY2023: -$1.8MNIVF FY2024: -$8.3MNIVF FY2025: -$11.1MSHC FY2019: $91.8MSHC FY2021: $67.1MSHC FY2021: $179.4MSHC FY2022: $95.6MSHC FY2023: -$362.7MSHC FY2024: $45.1MSHC FY2025: $149.2MFY19FY21FY22FY23FY24FY25
NIVF -$11.1MSHC $149.2M

Fiscal years as each company reports them; the two may end in different months.

Questions about NewGenIvf and Sotera Health

Which is bigger by revenue, NewGenIvf or Sotera Health?

Sotera Health is bigger by revenue: $1.2B in fiscal 2025, against $23.7M for NewGenIvf in fiscal 2025.

Which keeps more of its revenue as profit, NewGenIvf or Sotera Health?

NewGenIvf had a net margin of 41.7% in fiscal 2025; Sotera Health had 6.7% in fiscal 2025.

Which grew revenue faster, NewGenIvf or Sotera Health?

In their latest fiscal years revenue changed by +336.3% at NewGenIvf and +5.7% at Sotera Health.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies